My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 433

    1.

    Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

    Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators.

    Diabetes. 2001 Aug;50(8):1735-40.PMID: 11473032 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

    Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS.

    J Clin Endocrinol Metab. 2003 Jan;88(1):103-8.PMID: 12519837 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.

    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.

    Diabetologia. 1998 May;41(5):536-41.PMID: 9628270 [PubMed - indexed for MEDLINE]Related articles

    4.

    Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.

    Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J.

    J Autoimmun. 1999 Jun;12(4):279-87.PMID: 10330299 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diabetes Prevention Trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband.

    Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP.

    Ann N Y Acad Sci. 2002 Apr;958:254-8.PMID: 12021118 [PubMed - indexed for MEDLINE]Related articles

    6.

    Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.

    Gianani R, Verge CF, Moromisato-Gianani RI, Yu L, Zhang YJ, Pugliese A, Eisenbarth GS.

    J Autoimmun. 1996 Jun;9(3):423-5.PMID: 8816981 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.

    Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS.

    Diabetes. 1996 Jul;45(7):926-33.PMID: 8666144 [PubMed - indexed for MEDLINE]Related articles

    8.

    The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.

    Hatziagelaki E, Jaeger C, Petzoldt R, Seissler J, Scherbaum WA, Federlin K, Bretzel RG.

    Horm Metab Res. 1999 Oct;31(10):564-9.PMID: 10596966 [PubMed - indexed for MEDLINE]Related articles

    9.

    Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.

    Vardi P, Crisa L, Jackson RA.

    Diabetologia. 1991 Feb;34(2):93-102.PMID: 2065854 [PubMed - indexed for MEDLINE]Related articles

    10.

    Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.

    Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.

    Diabetologia. 2002 Jan;45(1):66-76.PMID: 11845225 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

    European Nicotinamide Diabetes Intervention Trial Group.

    Diabetologia. 2003 Mar;46(3):339-46. Epub 2003 Feb 27. Erratum in: Diabetologia. 2003 Sep;46(9):1296. PMID: 12687331 [PubMed - indexed for MEDLINE]Related articles

    12.

    The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.

    Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.

    Exp Clin Endocrinol Diabetes. 1999;107(8):496-505.PMID: 10612480 [PubMed - indexed for MEDLINE]Related articles

    13.

    Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

    Decochez K, Truyen I, van der Auwera B, Weets I, Vandemeulebroucke E, de Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

    Diabetologia. 2005 Apr;48(4):687-94. Epub 2005 Mar 9.PMID: 15756536 [PubMed - indexed for MEDLINE]Related articles

    14.

    Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.

    Park Y, Lee H, Takino H, Abiru N, Kawasaki E, Eisenbarth GS.

    Acta Diabetol. 2001;38(1):51-6.PMID: 11487177 [PubMed - indexed for MEDLINE]Related articles

    15.

    Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.

    Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG.

    J Clin Endocrinol Metab. 1994 May;78(5):1172-8.PMID: 8175975 [PubMed - indexed for MEDLINE]Related articles

    16.

    IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.

    Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.

    Diabetologia. 1997 Jan;40(1):95-9.PMID: 9028724 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

    Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.

    Pediatr Diabetes. 2005 Dec;6(4):184-92.PMID: 16390386 [PubMed - indexed for MEDLINE]Related articles

    18.

    Transmission of high-risk HLA-DQB1 alleles in Chilean type 1 diabetic patients and their parents: stratification by the presence of ICA or GAD65 autoantibodies.

    Pérez-Bravo F, Santos JL, Carrasco E, Calvillán M, Albala C, Puig-Domingo M, Piquer S, De Leiva A.

    Autoimmunity. 2001;33(4):285-91.PMID: 11683403 [PubMed - indexed for MEDLINE]Related articles

    19.

    Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.

    Korhonen S, Knip MM, Kulmala P, Savola K, Akerblom HK, Knip M; Finnish Study Group for ICA Screening.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):43-8.PMID: 11921417 [PubMed - indexed for MEDLINE]Related articles

    20.

    Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.

    Roll U, Christie MR, Standl E, Ziegler AG.

    Diabetes. 1994 Jan;43(1):154-60.PMID: 8262311 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity